Title |
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
|
---|---|
Published in |
Cancer Chemotherapy and Pharmacology, June 2009
|
DOI | 10.1007/s00280-009-1041-6 |
Pubmed ID | |
Authors |
Brian Thiessen, Clinton Stewart, Ming Tsao, Suzanne Kamel-Reid, Paula Schaiquevich, Warren Mason, Jacob Easaw, Karl Belanger, Peter Forsyth, Lynn McIntosh, Elizabeth Eisenhauer |
Mendeley readers
The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Korea, Republic of | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 92 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 19 | 20% |
Student > Ph. D. Student | 17 | 18% |
Student > Master | 11 | 12% |
Student > Doctoral Student | 7 | 7% |
Student > Bachelor | 4 | 4% |
Other | 12 | 13% |
Unknown | 25 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 23% |
Biochemistry, Genetics and Molecular Biology | 12 | 13% |
Agricultural and Biological Sciences | 12 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
Neuroscience | 5 | 5% |
Other | 8 | 8% |
Unknown | 31 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2015.
All research outputs
#7,856,604
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#688
of 2,501 outputs
Outputs of similar age
#39,825
of 116,306 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#4
of 14 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 116,306 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.